Results 21 to 30 of about 8,151 (283)

Have no fear, IR is here: A case of right brachiocephalic vein /svc recanalization for port placement [PDF]

Radiology Case Reports
A patient with a history of cystic fibrosis and bilateral lung transplant presented internal jugular port placement for extracorporeal photopheresis in the setting of acute rejection.
Garrett DePalma, DO, Tomas Mujo, DO
doaj   +2 more sources

Extracorporeal Photopheresis in Dermatological Diseases

International Journal of Molecular Sciences
Extracorporeal photopheresis (ECP) is an apheresis procedure that is conventionally used as a first-line treatment for cutaneous and leukemic subtypes of T-cell lymphoma, such as Sezary’s syndrome and mycosis fungoides.
Hanna Terhaar, Mohammad Saleem, Nabiha Yusuf   +2 more
semanticscholar   +3 more sources

Ruxolitinib Plus Extracorporeal Photopheresis for Steroid-Refractory Acute and Chronic Graft-Versus-Host Disease. [PDF]

J Clin Med Res
Halahleh K, Sultan I, Abu-Khader A, Al-Far R, Halahleh L, Abdel Rahman Z, Muradi I, Khattab E, Abu Jazar H.   +8 more
europepmc   +3 more sources

Extracorporeal Photopheresis for Chronic Graft-Versus-Host Disease According to 2014 NIH Consensus Criteria. [PDF]

J Clin Apher
ABSTRACT Chronic graft‐versus‐host disease (cGVHD) remains a major cause of morbidity and mortality following allogeneic hematopoietic stem cell transplantation. Many cGVHD patients require prolonged systemic immunosuppression with corticosteroids, which carry significant adverse effects, and alternative therapies are often required.
Goretsky Y, Holtzman N, Han S, Reis IM, Suzuki V, Jean P, Mones K, Diaz-Paez M, Benjamin C, Beitinjaneh A, Goodman M, Jimenez AJ, Lekakis L, Pereira D, Spiegel J, Wu Y, Green DJ, Komanduri KV, Wang TP.   +18 more
europepmc   +2 more sources

Treatment of graft versus host disease with photopheresis interferes in voriconazole therapeutic drug monitoring: A case study

Practical Laboratory Medicine, 2023
Extracorporeal photopheresis is an established procedure for refractory graft-versus-host disease, a major complication associated with notable morbidity and mortality in patients with allogeneic hematopoietic stem cell transplant.
Adriana Sassone, Juliana Testard, Andrea Saulo, Analia Julia, Paula Schaiquevich   +4 more
doaj   +1 more source

Application of Photodynamic Therapy with 5-Aminolevulinic Acid to Extracorporeal Photopheresis in the Treatment of Patients with Chronic Graft-versus-Host Disease: A First-in-Human Study

Pharmaceutics, 2021
Extracorporeal photopheresis (ECP), an immunomodulatory therapy for the treatment of chronic graft-versus-host disease (cGvHD), exposes isolated white blood cells to photoactivatable 8-methoxypsoralen (8-MOP) and UVA light to induce the apoptosis of T ...
Eidi Christensen, Olav A. Foss, Petter Quist-Paulsen, Ingrid Staur, Frode Pettersen, Toril Holien, Petras Juzenas, Qian Peng   +7 more
doaj   +1 more source

Extracorporeal Photopheresis (ECP) and the Potential of Novel Biomarkers in Optimizing Management of Acute and Chronic Graft vs. Host Disease (GvHD)

Frontiers in Immunology, 2020
As the use of hematopoietic stem cell transplantation (HSCT) has become a more widespread and effective treatment for hematological malignant and non-malignant conditions, the need to minimize the harmful effects of graft- vs.-host disease (GvHD) has ...
Matthew Mankarious, Nick C. Matthews, John A. Snowden, Arun Alfred, Arun Alfred   +4 more
doaj   +1 more source

Extracorporeal photopheresis and renal transplantation

Nefrología (English Edition), 2020
Saulo Fernández Granados, Ernesto Fernández Tagarro, Ana Ramírez Puga, Rita Guerra Rodríguez, Ingrid Auyanet Saavedra, Saavedra González Nuez, César García-Cantón, Fernando Fernández Fuertes, Manuel Tapia Martín   +8 more
doaj   +3 more sources

CLINICAL EFFICACY OF EXTRA-CORPOREAL PHOTOCHEMOTHERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS

Alʹmanah Kliničeskoj Mediciny, 2016
Aim: To assess clinical efficacy of extracorporeal photochemotherapy in patients with systemic lupus erythematosus (SLE). Materials and methods: 30 SLE patients were thoroughly examined.
A. V. Molochkov, A. V. Kil’dyushevskiy, O. V. Karzanov, L. S. Bagapsh   +3 more
doaj   +1 more source

Psoralen and ultraviolet A light treatment directly affects phosphatidylinositol 3-kinase signal transduction by altering plasma membrane packing [PDF]

, 2016
Psoralen and ultraviolet A light (PUNTA) are used to kill pathogens in blood products and as a treatment of aberrant cell proliferation in dermatitis, cutaneous T-cell lymphoma, and graft versus-host disease.
Compernolle, Veerle, Devloo, Rosalie, Feys, Hendrik, Sandra, Koen, t'Kindt, Ruben, Van Aelst, Britt, Vandekerckhove, Philippe, Zachée, Pierre   +7 more
core   +2 more sources